Are we there yet?

被引：2

作者：

Edmonson, JH ^{[1
]}

机构：

[1] Mayo Clin, Rochester, MN 55905 USA

来源：

GYNECOLOGIC ONCOLOGY | 2000年 / 79卷 / 02期

关键词：

D O I：

10.1006/gyno.2000.6033

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：145 / 146

页数：2

共 9 条

[1] Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy [J].

Czuczman, MS ;

Grillo-López, AJ ;

White, CA ;

Saleh, M ;

Gordon, L ;

LoBuglio, AF ;

Jonas, C ;

Klippenstein, D ;

Dallaire, B ;

Varns, C .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :268-276

[2] Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia [J].

Druker, BJ ;

Lydon, NB .

JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (01) :3-7

[3]

Druker BJ, 1999, BLOOD, V94, p368A

[4]

Gorai I, 1997, INT J CANCER, V72, P821, DOI 10.1002/(SICI)1097-0215(19970904)72:5<821::AID-IJC19>3.0.CO

[5]

2-B

[6] A RANDOMIZED CLINICAL-TRIAL OF ADJUVANT ADRIAMYCIN IN UTERINE SARCOMAS - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].

OMURA, GA ;

BLESSING, JA ;

MAJOR, F ;

LIFSHITZ, S ;

EHRLICH, CE ;

MANGAN, C ;

BEECHAM, J ;

PARK, R ;

SILVERBERG, S .

JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (09) :1240-1245

[7]

SUTTON GP, 1997, P ASCO, V16, pA362

[8]

VOGEL C, 2000, P AN M AM SOC CLIN, V19, pA71

[9]

Wada H, 1997, CANCER RES, V57, P5379

← 1 →